On Tuesday, IGC Pharma Inc (AMEX: IGC) opened higher 4.45% from the last session, before settling in for the closing price of $0.37. Price fluctuations for IGC have ranged from $0.25 to $0.48 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 12.85% annually for the last half of the decade. Company’s average yearly earnings per share was noted 11.11% at the time writing. With a float of $66.30 million, this company’s outstanding shares have now reached $84.14 million.
IGC Pharma Inc (IGC) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of IGC Pharma Inc is 26.99%, while institutional ownership is 3.35%. The most recent insider transaction that took place on Sep 25 ’24, was worth 200,000. In this transaction Director of this company bought 588,235 shares at a rate of $0.34, taking the stock ownership to the 942,402 shares.
IGC Pharma Inc (IGC) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.02 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.03) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.02 per share during the current fiscal year.
IGC Pharma Inc (AMEX: IGC) Trading Performance Indicators
Check out the current performance indicators for IGC Pharma Inc (IGC). In the past quarter, the stock posted a quick ratio of 0.46. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 26.63.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.08, a number that is poised to hit -0.02 in the next quarter and is forecasted to reach -0.08 in one year’s time.
Technical Analysis of IGC Pharma Inc (IGC)
Let’s dig in a bit further. During the last 5-days, its volume was 0.52 million. That was inferior than the volume of 1.24 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 67.85%.
During the past 100 days, IGC Pharma Inc’s (IGC) raw stochastic average was set at 65.95%, which indicates a significant decrease from 88.34% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0200 in the past 14 days, which was higher than the 0.0200 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.3464, while its 200-day Moving Average is $0.3289. However, in the short run, IGC Pharma Inc’s stock first resistance to watch stands at $0.4002. Second resistance stands at $0.4105. The third major resistance level sits at $0.4224. If the price goes on to break the first support level at $0.3780, it is likely to go to the next support level at $0.3661. Assuming the price breaks the second support level, the third support level stands at $0.3558.
IGC Pharma Inc (AMEX: IGC) Key Stats
There are currently 90,809K shares outstanding in the company with a market cap of 35.42 million. Presently, the company’s annual sales total 1,270 K according to its annual income of -7,120 K. Last quarter, the company’s sales amounted to 330 K and its income totaled -1,600 K.
